UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is rituximab effective in acquired von Willebrand syndrome?

British journal of haematology, 2009-03, Vol.144 (6), p.967-968

2009

Volltextzugriff (PDF)

A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin

Haematologica (Roma), 2008-05, Vol.93 (5), p.799-800

2008

Volltextzugriff (PDF)

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A

Blood, 2006-01, Vol.107 (1), p.46-51

2006

Volltextzugriff (PDF)

Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A

The Journal of pediatrics, 2021-07, Vol.234, p.212-219.e3

2021

Volltextzugriff (PDF)

Risk of inhibitors in haemophilia and the type of factor replacement

Current opinion in hematology, 2006-09, Vol.13 (5), p.316-322

2006

Volltextzugriff (PDF)

Associations between type of product and inhibitors in previously untreated patients (PUPs) with severe hemophilia: switches and particular products can disturb analysis

Blood, 2007-08, Vol.110 (3), p.1073-1074

2007

Volltextzugriff (PDF)

Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate

Thrombosis and haemostasis, 1999-10, Vol.82 (4), p.1247-1249

1999

Volltextzugriff (PDF)

Future perspective for the treatment of hemophilia A

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1320-1321

LAURIAN, Y.

2005

Volltextzugriff (PDF)

Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required

British journal of haematology, 2006-03, Vol.132 (6), p.798-799

2006

Volltextzugriff (PDF)

Glanzmann’s Thrombasthenia Treatment: A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII and Other Hemostatic Agents

Seminars in hematology, 2006, Vol.43 (1), p.S33-S36

2006

Volltextzugriff (PDF)

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

Pathophysiology of haemostasis and thrombosis, 2002-01, Vol.32 (Suppl 1), p.37-40

Laurian, Yves

2002

Volltextzugriff (PDF)

Aregenerative anemia and erythrocytes hemighosts: a case report

Annales de biologie clinique (Paris), 2011-07, Vol.69 (4), p.481-484

2011

Volltextzugriff (PDF)

Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution

Human mutation, 2006-07, Vol.27 (7), p.676-685

2006

Volltextzugriff (PDF)

Anémie non régénérative et hématies fantômes: à propos d'un cas

Annales de biologie clinique (Paris), 2011-07, Vol.69 (4), p.481-484

2011

Volltextzugriff (PDF)

Treatment of congenital afibrinogenemia in a premature neonate

The Annals of pharmacotherapy, 2008-07, Vol.42 (7), p.1145-1146

2008

Volltextzugriff (PDF)

Aregenerative anemia and erythrocytes hemighosts: a case report

Annales de biologie clinique (Paris), 2011-07, Vol.69 (4), p.481-484

2011

Volltextzugriff (PDF)

Red blood cell transfusion in patients with type 1 Glanzmann's thrombasthenia

Journal of thrombosis and haemostasis, 2005-10, Vol.3 (10), p.2346

2005

Volltextzugriff (PDF)

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-03, Vol.8 (2), p.91-97

2002

Volltextzugriff (PDF)

Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-09, Vol.11 (5), p.433-437

2005

Volltextzugriff (PDF)

Haemophilia B Due to a De Novo Insertion of a Human-Specific Alu Subfamily Member within the Coding Region of the Factor IX Gene

European journal of human genetics : EJHG, 1993-01, Vol.1 (1), p.30-36

1993

Volltextzugriff (PDF)

Progression to AIDS in French haemophiliacs : association with HLA-B35

AIDS (London), 1993-04, Vol.7 (4), p.497-500

1993

Volltextzugriff (PDF)

SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACS

The Lancet (British edition), 1986-11, Vol.328 (8518), p.1233-1236

1986

Volltextzugriff (PDF)

Long-Term Evaluation of HIV Antigen and Antibodies to p24 and gp41 in Patients with Hemophilia

The New England journal of medicine, 1987-10, Vol.317 (18), p.1114-1121

1987

Volltextzugriff (PDF)

Splenectomy Is Safe and Effective in Human Immunodeficiency Virus-Related Immune Thrombocytopenia

Blood, 1993-07, Vol.82 (1), p.29-32

1993

Volltextzugriff (PDF)

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate

Thrombosis and haemostasis, 1995-02, Vol.73 (2), p.215-218

1995

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(42)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Hematology
(20)
Male
(18)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Adult
(11)
Child
(9)
Female
(9)
Middle Aged
(9)
Hematologic And Hematopoietic Diseases
(8)
Cardiovascular System & Cardiology
(7)
Child, Preschool
(7)
Follow-Up Studies
(7)
Peripheral Vascular Disease
(7)
Recombinant Proteins - Therapeutic Use
(7)
Aged
(6)
Aids/hiv
(6)
Platelet Diseases And Coagulopathies
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is rituximab effective in acquired von Willebrand syndrome?

A natural variant with a point mutation resulting in a homozygous Arg to His substitution at position 388 in prothrombin

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A

Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A

Risk of inhibitors in haemophilia and the type of factor replacement

Associations between type of product and inhibitors in previously untreated patients (PUPs) with severe hemophilia: switches and particular products can disturb analysis

Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate

Future perspective for the treatment of hemophilia A

Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required

Glanzmann’s Thrombasthenia Treatment: A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII and Other Hemostatic Agents

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

Aregenerative anemia and erythrocytes hemighosts: a case report

Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution

Anémie non régénérative et hématies fantômes: à propos d'un cas

Treatment of congenital afibrinogenemia in a premature neonate

Aregenerative anemia and erythrocytes hemighosts: a case report

Red blood cell transfusion in patients with type 1 Glanzmann's thrombasthenia

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery

Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group

Haemophilia B Due to a De Novo Insertion of a Human-Specific Alu Subfamily Member within the Coding Region of the Factor IX Gene

Progression to AIDS in French haemophiliacs : association with HLA-B35

SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACS

Long-Term Evaluation of HIV Antigen and Antibodies to p24 and gp41 in Patients with Hemophilia

Splenectomy Is Safe and Effective in Human Immunodeficiency Virus-Related Immune Thrombocytopenia

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate

Suchergebnisse filtern